Cadrenal Therapeutics Inc
CVKD8.810USD
-1.520-14.71%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
8.810USD+8.810After-hours (ET)
16.82MMarket Cap
LossP/E TTM
Cadrenal Therapeutics Inc
8.810
-1.520-14.71%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-153.15%-4.65M
-157.86%-1.79M
-250.64%-2.20M
-92.28%-1.53M
-29.98%-1.84M
-139.29%-694.45K
-50.29%-627.78K
-75.51%-795.31K
-3133.01%-1.41M
---290.22K
---417.71K
---453.14K
---43.70K
Net income from continuing operations
-131.19%-3.85M
-266.00%-4.19M
-132.31%-2.41M
-138.58%-2.39M
67.85%-1.66M
77.16%-1.14M
-1.01%-1.04M
-99.75%-1.00M
-2828.75%-5.17M
---5.01M
---1.03M
---502.14K
---176.65K
Operating gains losses
824.12%5.52K
-31.83%407.00
-31.99%406.00
-21.14%470.00
214.21%597.00
-21.45%597.00
17.98%597.00
--596.00
--190.00
--760.00
--506.00
----
----
Other non-cash items
100.00%0.00
-245.83%-35.00
-219.10%-106.00
-217.78%-106.00
-100.00%-105.00
-99.94%24.00
-99.52%89.00
-98.92%90.00
149572.85%3.75M
--37.61K
--18.47K
--8.32K
--2.51K
Change in working capital
-303.69%-1.36M
372.13%1.63M
-136.75%-93.67K
1609.48%670.25K
32.15%-336.31K
-2.23%345.88K
185.04%254.92K
9.99%39.21K
-484.55%-495.70K
--353.75K
--89.43K
--35.65K
--128.90K
-Change in prepaid expenses
-161.32%-533.35K
42.15%112.20K
-35.06%43.24K
-12.78%58.82K
27.09%-204.09K
5888.54%78.93K
1720.34%66.59K
364.61%67.44K
-12588.67%-279.91K
--1.32K
--3.66K
---25.48K
---2.21K
-Change in other current assets
----
----
----
----
-100.00%0.00
99.97%-1.00
--1.00
99.91%-1.00
300.18%2.20K
---3.79K
--0.00
---1.10K
---1.10K
Cash from non-recurring investing activities
Cash from operating activities
-153.15%-4.65M
-157.86%-1.79M
-250.64%-2.20M
-92.28%-1.53M
-29.98%-1.84M
-139.29%-694.45K
-50.29%-627.78K
-75.51%-795.31K
-3133.01%-1.41M
---290.22K
---417.71K
---453.14K
---43.70K
Investing cash flow
Net cash flow from investment products
---3.25K
---6.54K
----
----
----
100.00%0.00
99.96%-1.00
---3.25K
----
---1.00
---2.28K
----
----
Cash from non-current investing activities
Net cash flow from investing activities
---3.25K
---6.54K
----
----
----
100.00%0.00
99.96%-1.00
---3.25K
----
---1.00
---2.28K
----
----
Financing cash flow
Cash flow from continuous financing activities
661019.46%1.97M
59710.28%7.45M
-76.52%1.53M
--0.00
-99.99%298.00
-105.69%-12.50K
1304.20%6.51M
-100.00%0.00
968.80%5.41M
--219.72K
--463.42K
--50.45K
--506.04K
Net cash flow from debt Issuance/repayment
----
----
----
----
100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-150.15%-250.00K
--219.72K
--463.42K
--50.00K
--498.54K
Net cash flow from common stock issuance/repurchase
--2.06M
66739.57%8.33M
-76.52%1.53M
----
-100.00%0.00
---12.50K
--6.51M
-100.00%0.00
72014.33%5.41M
--0.00
--0.00
--450.00
--7.50K
Proceeds from issuance of warrants
----
---541.02K
--0.00
--0.00
-99.88%298.00
--0.00
--0.00
--0.00
--250.00K
----
--0.00
----
--0.00
Net cash flow from other financing activities
---85.33K
---337.64K
----
----
----
----
----
----
----
----
----
----
----
Net cash from non-recurrent financing activities
Net cash from financing activities
661019.46%1.97M
59710.28%7.45M
-76.52%1.53M
--0.00
-99.99%298.00
-105.69%-12.50K
1304.20%6.51M
-100.00%0.00
968.80%5.41M
--219.72K
--463.42K
--50.45K
--506.04K
Net cash flow
Beginning cash balance
19.23%10.02M
-52.09%4.36M
55.96%5.04M
63.00%6.57M
25685.61%8.40M
8737.09%9.11M
5314.96%3.23M
771.30%4.03M
--32.59K
--103.08K
--59.65K
--462.34K
--0.00
Current period cash flow changes
-46.06%-2.68M
899.79%5.65M
-111.45%-673.27K
-91.50%-1.53M
-145.95%-1.84M
-902.82%-706.95K
13436.33%5.88M
-98.30%-798.56K
764.25%4.00M
---70.50K
--43.44K
---402.69K
--462.34K
Ending cash balance
11.72%7.34M
19.23%10.02M
-52.09%4.36M
55.96%5.04M
63.00%6.57M
25685.61%8.40M
8737.09%9.11M
5314.96%3.23M
771.30%4.03M
--32.59K
--103.08K
--59.65K
--462.34K
Free cash flow
---4.65M
-157.86%-1.79M
----
----
----
-139.29%-694.45K
-50.29%-627.78K
---795.31K
----
---290.22K
---417.71K
----
----
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
